TrialBiology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation2020

A Phase 3 Randomized Study of Remestemcel-L versus Placebo Added to Second-Line Therapy in Patients with Steroid-Refractory Acute Graft-versus-Host Disease.

Partow Kebriaei et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.